Glaukos Corporation
GKOSNYSEHealthcareMedical Devices
As of Oct 23, 2026 close
- Market cap
- $10.52B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $73.16$191.62
- Volume (live)
- -
- Avg. volume (3M)
- 934.53K
Glaukos (GKOS) Stock Price & Financial Analysis
Glaukos Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $173.08 - $179.70 |
|---|---|
| 52-Week High | $191.62 |
| 52-Week Low | $73.16 |
| Open | $175.95 |
| Volume (last close) | 961.23K |
| Average Volume (3M) | 934.53K |
| Revenue (TTM) | 612.84M |
|---|---|
| Net Income (TTM) | -188.05M |
| Free Cash Flow (TTM) | -12.20M |
| EPS (TTM) | −$3.25 |
| Profit Margin | -30.68% |
| Operating Margin | -13.13% |
| Return on Equity (ROE) | -27.55% |
| Debt to Equity | 0.15 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 10.52B |
|---|---|
| Shares Outstanding | 58.82M |
| Price to Sales (P/S) | 17.17 |
| Price to Book (P/B) | 15.42 |
| EV/EBITDA | -70.32 |
| 50-Day MA | $171.96 |
|---|---|
| 200-Day MA | $138.14 |
| 1-Year Change | +134.77% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Glaukos at a Glance
As of the Oct 23, 2026 close, Glaukos (GKOS) has a market capitalization of $10.52B. The stock trades at 17.2× sales. Over the trailing twelve months it lost $188.05M on revenue of $612.84M and burned $12.20M of free cash flow. Revenue grew 41.5% year over year.
As of its latest reported balance sheet, it holds $114.48M in cash and securities against $102.84M of debt, a net cash position of $11.65M.
Glaukos does not currently pay a dividend.
The share price is up 134.8% over the past year. At $178.88 (the Oct 23, 2026 close) it sits near the top of its 52-week range of $73.16 to $191.62, above its 200-day moving average of $138.14.
Based on 14 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $197.58, 10.5% above the Oct 23, 2026 close.
Frequently Asked Questions About Glaukos
What is the current stock price for GKOS?
As of the Oct 23, 2026 close, GKOS stock trades at $178.88. The 52-week range is $73.16–$191.62, with a day range of $173.08–$179.70.
What is the P/E ratio for GKOS?
The P/E ratio (Price-to-Earnings) for GKOS is shown in the Key Statistics section. This valuation metric helps compare Glaukos Corporation to industry peers.
Does GKOS pay dividends?
Glaukos does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for GKOS?
Based on ratings from 14 professional analysts over the last 90 days, the consensus for GKOS is Buy. The average 12-month price target is $197.58, a 10.5% upside from the Oct 23, 2026 close of $178.88.
What is the market cap of GKOS?
As of the Oct 23, 2026 close, Glaukos's market capitalization is $10.52B, classifying it as a large-cap company. Glaukos operates in the Healthcare sector within the Medical Devices industry.